title: [Effectiveness of the treatment of arterial hypertension in a specialized service. An audit using the automatic measurement of arterial blood pressure].
abstract: The ineluctable fade out of mercury sphingomanometer pressure device involve the necessity in using automatic blood pressure systems. In parallel the recent PHARE II study witness of a lack in the control of hypertension in general practice. In the basis of an automatic blood pressure device measure, we had try to know the efficiency of blood pressure contrôl (BPC) in a specialised consultation.
  
  
  METHODS
  100 patients with essential systolo-diastolic hypertension (HTA) were screened. An independent physician measured the blood pressure level with an OMRON 705 CP device 3 times. The acceptable BPC was considered less than 160/95 mmHg and the optimal BPC less than 140/90 mmHg. There was 70 man, 30 female (mean age = 67 year old). The initial mean blood pressure was 169/104 mmHg.
  
  
  RESULTS
  The final blood pressure measured was 137/80 mmHg. The percentage of patients who have an acceptable contrôl (< 160/95) was 91% and an optimal contrôl (< 140/90) 66%. 12% of these 66 maintain a height cardio-vascular risk. The mean number of medication used was 2 and it's paradoxally not differ between the optimal blood pressure control group and the other patients who need probably an intensive medication. In conclusion these study shows us the importance in understanding our patients particularity in order to increase the treatment efficiency.
authors.affiliation: Service de médecine interne angéiologie-hypertension artérielle, CHU La Timone, Marseille.
authors.forename: F
authors.initials: F
authors.lastname: Silhol
authors.forename: J
authors.initials: J
authors.lastname: Colonna
authors.forename: K
authors.initials: K
authors.lastname: Bouchlaghem
authors.forename: B
authors.initials: B
authors.lastname: Vaisse
authors.forename: L
authors.initials: L
authors.lastname: Poggi
mesh_terms: D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D001795:Blood Pressure Determination / Q000295:instrumentation / Q000379:methods*; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006757:Hospital Units; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D008485:Medical Audit; D012307:Risk Factors; D012737:Sex Factors; D019722:Sphygmomanometers; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations